Business ExpandingNextrove, a system integrator specializing in the life science sector, established a Japanese subsidiary in Tokyo.

Nextrove is a global company based in New Jersey, USA, supporting the digitalization of medical information and drug safety management. It provides services related to drug safety monitoring (PV/Pharmacovigilance), electronic quality management system (EQMS), system integration of medical information, and regulatory compliance/and its management for pharmaceutical products to cater for ever increasing demand.

With operations in the U.S., Canada, EU, China, and Japan, and a development base in India, a team of over 160 global and extensive industry-experienced members propose solutions that meet the business needs of life science companies. The company's motto is "Think globally and implement locally."

Nextrove has entered partnerships with Oracle and ArisGlobal, which develop world-class systems, and is working on many projects around the world. It also hosts Oracle's "Argus" on its cloud service, "Nextcloud," to provide optimal solutions for small and medium-sized companies.

As a product portfolio, the company developed the "Progressive Platform," a suite of applications that allows clients to maximize efficiency. It offers a wide range of products, including "Progressive MICC," a medical information contact center solution designed for clinical research organizations; "Progressive INTAKE," which optimizes and simplifies Intake operations; "Progressive COMPLIANCE," which automates the preparation, scheduling, and tracking of periodic safety reports; and "Progressive CONVEY," a platform for distributing safety-related documents.

The company established Nextrove Japan GK in August 2020 to better support existing partners and clients, and cultivate new ones. At the Japanese practice, consultants familiar with the regulatory requirements of the Pharmaceuticals and Medical Devices Agency (PMDA) provide consulting services to support with pharmacovigilance and other issues faced by Japanese pharmaceutical companies.